vs
Crescent Energy Co（CRGY）与爱德华生命科学（EW）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Crescent Energy Co的1.9倍（$1.6B vs $865.0M），爱德华生命科学净利率更高（23.1% vs -1.0%，领先24.1%），爱德华生命科学同比增速更快（16.7% vs -1.2%），过去两年Crescent Energy Co的营收复合增速更高（14.7% vs 9.7%）
新月石油是中东地区成立最早、规模最大的私营上游油气企业，1971年成立，总部位于阿联酋沙迦酋长国，目前在阿联酋和伊拉克库尔德斯坦地区均有业务布局。截至2023年，公司已与伊拉克石油部签署三份为期20年的合同，助力伊拉克油气产业重建。
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
CRGY vs EW — 直观对比
营收规模更大
EW
是对方的1.9倍
$865.0M
营收增速更快
EW
高出17.9%
-1.2%
净利率更高
EW
高出24.1%
-1.0%
两年增速更快
CRGY
近两年复合增速
9.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $865.0M | $1.6B |
| 净利润 | $-8.7M | $380.7M |
| 毛利率 | — | 78.0% |
| 营业利润率 | -6.2% | 1.8% |
| 净利率 | -1.0% | 23.1% |
| 营收同比 | -1.2% | 16.7% |
| 净利润同比 | 92.7% | 6.8% |
| 每股收益（稀释后） | — | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRGYEW
| Q1 26 | — | $1.6B | ||
| Q4 25 | $865.0M | $1.6B | ||
| Q3 25 | $866.6M | $1.6B | ||
| Q2 25 | $898.0M | $1.5B | ||
| Q1 25 | $950.2M | $1.4B | ||
| Q4 24 | $875.3M | $1.4B | ||
| Q3 24 | $744.9M | $1.4B | ||
| Q2 24 | $653.3M | $1.4B |
净利润CRGYEW
| Q1 26 | — | $380.7M | ||
| Q4 25 | $-8.7M | $91.2M | ||
| Q3 25 | $-9.5M | $291.1M | ||
| Q2 25 | $153.2M | $333.2M | ||
| Q1 25 | $-2.1M | $358.0M | ||
| Q4 24 | $-118.0M | $385.6M | ||
| Q3 24 | $-9.9M | $3.1B | ||
| Q2 24 | $37.5M | $366.3M |
毛利率CRGYEW
| Q1 26 | — | 78.0% | ||
| Q4 25 | — | 78.1% | ||
| Q3 25 | — | 77.8% | ||
| Q2 25 | — | 77.5% | ||
| Q1 25 | — | 78.7% | ||
| Q4 24 | — | 78.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 79.9% |
营业利润率CRGYEW
| Q1 26 | — | 1.8% | ||
| Q4 25 | -6.2% | 9.6% | ||
| Q3 25 | 3.6% | 19.8% | ||
| Q2 25 | 8.9% | 26.8% | ||
| Q1 25 | 18.1% | 27.9% | ||
| Q4 24 | -3.1% | 22.6% | ||
| Q3 24 | -1.0% | 25.9% | ||
| Q2 24 | 18.3% | 26.8% |
净利率CRGYEW
| Q1 26 | — | 23.1% | ||
| Q4 25 | -1.0% | 5.8% | ||
| Q3 25 | -1.1% | 18.7% | ||
| Q2 25 | 17.1% | 21.7% | ||
| Q1 25 | -0.2% | 25.3% | ||
| Q4 24 | -13.5% | 27.8% | ||
| Q3 24 | -1.3% | 226.7% | ||
| Q2 24 | 5.7% | 26.7% |
每股收益（稀释后）CRGYEW
| Q1 26 | — | $0.66 | ||
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | $0.50 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | — | $0.61 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | — | $5.13 | ||
| Q2 24 | — | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.2M | — |
| 总债务越低越好 | $5.5B | — |
| 股东权益账面价值 | $5.2B | — |
| 总资产 | $12.4B | — |
| 负债/权益比越低杠杆越低 | 1.07× | — |
8季度趋势，按日历期对齐
现金及短期投资CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | $10.2M | $4.2B | ||
| Q3 25 | $3.5M | $3.8B | ||
| Q2 25 | $3.1M | $4.1B | ||
| Q1 25 | $6.3M | $3.9B | ||
| Q4 24 | $132.8M | $4.0B | ||
| Q3 24 | $136.2M | $4.4B | ||
| Q2 24 | $778.1M | $2.0B |
总债务CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.6B | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $2.4B | — |
股东权益CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $10.3B | ||
| Q3 25 | $4.5B | $10.2B | ||
| Q2 25 | $4.5B | $10.5B | ||
| Q1 25 | $3.3B | $10.1B | ||
| Q4 24 | $3.1B | $10.0B | ||
| Q3 24 | $2.9B | $9.5B | ||
| Q2 24 | $2.1B | $7.4B |
总资产CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | $12.4B | $13.7B | ||
| Q3 25 | $9.7B | $13.3B | ||
| Q2 25 | $9.9B | $13.5B | ||
| Q1 25 | $9.9B | $13.0B | ||
| Q4 24 | $9.2B | $13.1B | ||
| Q3 24 | $9.3B | $13.0B | ||
| Q2 24 | $7.5B | $10.1B |
负债/权益比CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | 1.07× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 1.10× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $371.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | $371.0M | $450.9M | ||
| Q3 25 | $473.1M | $573.7M | ||
| Q2 25 | $499.0M | $290.2M | ||
| Q1 25 | $337.1M | $280.4M | ||
| Q4 24 | $384.4M | $-127.5M | ||
| Q3 24 | $368.0M | $351.8M | ||
| Q2 24 | $286.9M | $371.5M |
自由现金流CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | — | $353.5M | ||
| Q3 25 | — | $516.2M | ||
| Q2 25 | — | $240.9M | ||
| Q1 25 | — | $224.4M | ||
| Q4 24 | — | $-177.3M | ||
| Q3 24 | — | $299.9M | ||
| Q2 24 | — | $286.1M |
自由现金流率CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | — | 33.2% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 15.9% | ||
| Q4 24 | — | -12.8% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 20.9% |
资本支出强度CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 6.2% |
现金转化率CRGYEW
| Q1 26 | — | — | ||
| Q4 25 | — | 4.94× | ||
| Q3 25 | — | 1.97× | ||
| Q2 25 | 3.26× | 0.87× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | -0.33× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | 7.64× | 1.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRGY
| Oil Reserves | $554.3M | 64% |
| Natural Gas Production | $182.6M | 21% |
| Natural Gas Liquids Reserves | $92.3M | 11% |
| Midstream And Other | $35.8M | 4% |
EW
暂无分部数据
